🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The Purpose of this trial is: * to determine complete response rate (CRR) ...
Status
Completed
Location
1st Dept. of Medicine, Cologne University Hospital
Start Date
2012-10
Trial ID
NCT01569204
The purpose of this study is to find out if there is a benefit of adding He...
Status
Completed
Location
Hays Medical Center
Start Date
2009-07
Trial ID
NCT00944047
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Terminated
Location
Banner Thunderbird Medical Center
Start Date
1997-08
Trial ID
NCT00005047
Treatments Being Tested
The CHIP-AML22 Master protocol has the overall aim of increasing the cure r...
Status
Recruiting
Location
Princess Máxima Center for pediatric oncology
Start Date
2024-02-06
Trial ID
NCT06262438
This is an open-label, multicenter, randomized phase II trial to evaluate t...
Status
Unknown
Location
UZLeuven
Start Date
2017-08-30
Trial ID
NCT03340376
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Status
Unknown
Location
Meander Medisch Centrum
Start Date
2001-02
Trial ID
NCT00028717
Treatments Being Tested
Chemotherapy is an important therapeutic method for patients with advanced ...
Status
Unknown
Location
Jinling Hospital
Start Date
2015-01-04
Trial ID
NCT02338518
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Status
Completed
Location
CCOP - Scottsdale Oncology Program
Start Date
1994-01
Trial ID
NCT00002548
This pilot study is evaluating how well pembrolizumab and combination chemo...
Status
Completed
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2020-11-24
Trial ID
NCT04383743
This phase I trial tests the safety, side effects, and best dose of combina...
Status
Recruiting
Location
Los Angeles General Medical Center
Start Date
2024-02-06
Trial ID
NCT05711615